default author photo

Zhiyue Huang

BeiGene (Shanghai) Co., Ltd

Shanghai

China

SCHOLARLY PAPERS

1

DOWNLOADS

70

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Dynamics of Serum Tumor Markers Predict Benefit from Immune Checkpoint Inhibitors in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Number of pages: 34 Posted: 19 Dec 2019
Zhibo Zhang, Fang Yuan, Runzhe Chen, Ye Li, Junxun Ma, Xiang Yan, Lijie Wang, Fan Zhang, Haitao Tao, Dong Guo, Zhiyue Huang, Sujie Zhang, Xiaoyan Li, Xiaoyu Zhi, Xiangwei Ge, Yi Hu and Jinliang Wang
Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, University of Texas at Houston - Department of Thoracic/Head and Neck Medical Oncology, Government of the People's Republic of China - First Medical Center, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, BeiGene (Shanghai) Co., Ltd, BeiGene (Shanghai) Co., Ltd, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology, Government of the People's Republic of China - Department of Oncology and Government of the People's Republic of China - Department of Oncology
Downloads 70 (875,328)

Abstract:

Loading...

Non-small cell lung cancer, serum tumor markers, Chinese patients, immune checkpoint inhibitors, efficacy